Aaron Richardson, DO
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1902291107
Payments from drug & device makers
What this record shows
This record is dominated by grants: $42,000 of the $50,850 with a category attached, or 82.6%. Medtronic accounts for 89.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $26,811 and has fallen 96.4% since, to $965 in 2025.
Across 121 payments — averaging $420.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$46K
- Philips North America LLC$3K
- Abbott$535
- Biosense Webster, Inc.$239
- Merck$218
- Boston Scientific$196
- plus $704 from 18 others
What the payments were for
- Grants$42,00083%
- Travel & lodging$3,6597%
- Food & beverage$4,97510%
- Education$2160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 55 | $45,530 |
| Philips North America LLC | 4 | $3,428 |
| Abbott | 5 | $535 |
| Biosense Webster, Inc. | 8 | $239 |
| Merck | 10 | $218 |
| Boston Scientific | 4 | $196 |
| Cardiva Medical, Inc. | 7 | $145 |
| Pfizer | 5 | $102 |
| Novo Nordisk | 3 | $61 |
| Cvrx, Inc. | 3 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Boehringer Ingelheim | 1 | $31 |
| Edwards Lifesciences | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| BD | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Hydrofera LLC | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
| Cordis US CORP. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9124) LM Undivided$3,259
- Micra$569
- NA$286
- ARCTIC FRONT ADVANCE$259
- ENSITE PRECISION$175
- AVEIR$171
- QDOT MICRO Catheter$143
- ENSITE$141
- COBALT DR MRI SURESCAN$129
- RESONATE EL ICD VR$124
- ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY$103
How this compares
$50,850 in reported general payments places this provider in the 75th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 178 | $150,819 |
| XareltoRivaroxaban | 39 | $34,459 |
| Dofetilide | 44 | $3,834 |
| Metoprolol Succinate | 131 | $1,977 |
| Amiodarone Hcl | 47 | $1,821 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 39 | $946 |
| Digoxin | 46 | $614 |
| Flecainide Acetate | 24 | $328 |
| Metoprolol Tartrate | 105 | $327 |
| Carvedilol | 19 | $271 |
| SotalolSotalol Hcl | 15 | $235 |
| Pantoprazole Sodium | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $102 | $150,819178 claims |
| Johnson & JohnsonXarelto | $15 | $34,45939 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Bruce StamblerAtlanta$91K
- Stacy WestermanAtlanta$60K
- Ashish BhimaniAtlanta$51K
- Devinder DhindsaAtlanta$47K
- Ahmadreza KarimianpourAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.